ARS Pharmaceuticals, Inc. (SPRY)
8.39
+0.15
(+1.82%)
USD |
NASDAQ |
Mar 13, 16:00
8.395
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals EPS Diluted (Quarterly) : -0.4172 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CVS Health Corp. | 2.305 |
| Thermo Fisher Scientific, Inc. | 5.210 |
| Krystal Biotech, Inc. | 1.699 |
| Guardian Pharmacy Services, Inc. | 0.3289 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.32M |
| Revenue (Quarterly) | 28.09M |
| Total Expenses (Quarterly) | 69.41M |
| Enterprise Value | 681.32M |
| Gross Profit Margin (Quarterly) | 78.09% |
| Profit Margin (Quarterly) | -147.1% |
| Earnings Yield | -20.71% |
| Normalized Earnings Yield | -20.71 |